2025-03-07
содержание
ʻO ka laweʻana i ka laweʻana i ka lāʻau lapaʻau no ka maʻi maʻi Hoʻopau i nā pahuhopu e hoʻomaikaʻi i nā hana lapaʻau a hōʻemi i nā hopenaʻaoʻao e ka hāʻawiʻana i nā mea hoʻokele i nā mea maʻi maʻi maʻi. ʻO kēia neʻeʻana i nā mea lawe i nā mea lawe a me nā mea hoʻolālā e hoʻonui ai i ka hoʻopiʻiʻana i ka dumus i loko o ka michion o ka michion, ke alakaʻi nei i nā hopena maikaʻi.
ʻO ka laweʻana i ka laweʻana i ka lāʻau lapaʻau no ka maʻi maʻi he ala paʻakikī loa o ka lawelaweʻana i ka lāʻau lapaʻau pololei pololei i nā cet cell cell. E like me keʻano maʻamau chimotherapy, kahi e pili ana i ke kino holoʻokoʻa, nā'ōnaehana helu helu i nā mea e pili ana i ka laweʻana i nā lāʻau lapaʻau kūikawā. Hoʻopilikiaʻia kēia kaʻina hana i nā pōʻino i ke olakino olakino a hōʻemi i nā hopenaʻokoʻa i pili pinepineʻia e pili ana i nā maʻi maʻi maʻi maʻamau.
Ka pahuhopu mua o ʻO ka laweʻana i ka laweʻana i ka lāʻau lapaʻau no ka maʻi maʻi ʻo ia ka hoʻonuiʻana i ka hopena o ka maʻi maʻi maʻi maʻi e hōʻemi ana i nā hopena o nā meaʻona ma nā wahi olakino. Ma ka hāʻawiʻana i nā lāʻau lapaʻau pololei i ke kūpeku i ka nui, hiki i nā mea kiʻekiʻe ke loaʻa i kaʻauhauʻo TherapeUtic Hiki ke hoʻokō i ka pūnaewele i hanaʻia, e hoʻomaikaʻi ana i nā manawa kūpono o ka mālamaʻana. Ua hōʻemiʻia kēia i ka hoʻolahaʻana i ka lāʻau lapaʻau i ka lāʻau lapaʻau, alakaʻi i nā mea liʻiliʻi a me nā hopena liʻiliʻi loa no ka mea maʻi.
ʻO nā mea e pili ana i nā mea e hilinaʻi nei i nāʻano kūlohelohe o nā mea nui, e like me kā lākou leta a me ka nui o ka damchatatic drainage. Nanoport me ka nui kūpono a me nā waiwai o nā papa e hiki ke hoʻohana i kēia mau hiʻohiʻona i nā mea nui e loaʻa ai. ʻO kekahi hiʻohiʻona he mau liposomes e like me nā scourical schools i huiʻia i loko o nā bilayers lipoid.
Hoʻokomoʻia ka pahuhopu ikaika e hoʻopili ana i nā mea lawe lāʻau lapaʻau me nā ligands kūikawā e hoʻopili ai i nā mea hoʻokipa ma luna o nā cell cell cell. Hoʻopili kēia pilina i ke koho koho i ka laweʻana i ka mea lawe lāʻau ma o nā ceta cet cell. ʻO nā ligand maʻamau i nā antibodies antibodies, peptides, a me nā mea hoʻohui.
ʻO ka mea e nānā ai ka mea pane i keʻano a i waho paha. E like me keʻano o ka ph Hiki i kēia ala ke hoʻokaʻawale i ka mana kūpono ma luna o ka laweʻana i ka lāʻau lapaʻau, e hoʻonui ana i ka hopena o ka mea e hōʻemi ai i ka hanaʻana i nā hopena hopena. PH-sentitive Nanooport
Ua hoʻohana nuiʻia nā Nanoparticles e like me nā mea lawe i loko ʻO ka laweʻana i ka laweʻana i ka lāʻau lapaʻau no ka maʻi maʻi Ma muli o kā lākou liʻiliʻi liʻiliʻi, wahi nui, a me ka version. Hiki ke hanaʻia lākou mai nā mea likeʻole, me nā lipids, ka polymers, a me nā hui pū. Hiki ke hoʻonuiʻia nā Nanoport e hoʻolaha i nā lāʻau lapaʻau, pale iā lākou mai ka degradation, a hoʻomaʻamaʻa i ko lākou laweʻana i nā cell cell. 'Ōlelo Shandong banufa cancer noiʻi noiʻi Hoʻohana i nāʻano inoa inoaʻo NaNoport
ʻO nā liposomes he scerical schools i hoʻohuiʻia i nā bilayers lipid. He biocompable biocompatible, biodegradable, a hiki ke hoʻomaopopo i ka hydropophilic a me nā lāʻau hydrophobic a me nā lāʻau hydrophobic a me nā lāʻau hydrophobic. Hiki ke hoʻololiʻia nā liposome i nā ligands e hoʻonui i ko lākou koho no ka cell cell cell.
Ua hoʻopiliʻia nā adcs o kahi antiblonal antiblonal i hoʻopiliʻia i kahi lāʻau lapaʻau cytototox. ʻO ka antiody koho koho i nā Cancer Canll, e hāʻawi ana i ka lāʻau lapaʻau pololei i ka pūnaewele Tumor. E hui pū ana kēia ala i ka kiko'ī o nā antibodies me ka potency o nā lāʻau lapaʻau cytototox.
Draxil? he hana liposalmal e hana ana i ka derorubicinin, kahi antracycline chemotherapy i ka lāʻau lapaʻau. ʻO ka loliʻana o ka liposibulan e hōʻoia i ka manawaʻo Derorusubicin i kona manawa a hoʻonui i kona hōʻiliʻiliʻana i nā'āpana me ka leʻaʻole. Draxil? ua aponoia no ka malama ana o ka kane o Ovarian o ka kanesa, he nui myeloma, a me ka srccoma.
Kadcyla? he adc i hakuʻia i ka trastuzumab, he antinidal antibody e nānā ana i kāna mea e pili ana iā Her2 Kadcyla? ua aponoia ia no ka hoolapanai ana o kana kane kanesa. ʻO keʻano trastuzumab o Kadcyla? ʻO nā Binds i Her2
Kekahi o nā pilikia nui i loko ʻO ka laweʻana i ka laweʻana i ka lāʻau lapaʻau no ka maʻi maʻi he mau mea waiwai nui e kū ana, e like me ka pale umauma koko a me ka dumor microvironment. ʻO nā hoʻolālā e lanakila ai i kēia mau mea paʻa e pili ana i ka hoʻohanaʻana iā NaNoport
Ka hoʻomaikaʻiʻana i ka'ōlelo kiko'ī o nā'ōnaehana lawe kālā i kohoʻia e hōʻemiʻia e hōʻemi i nā hopena kūpono a me ka hoʻonuiʻana i ka hopena o ka hana. Hiki ke loaʻa i kēia ma ka hoʻomohalaʻana i nā ligand koho balota, e kali ana i ka hoʻolālāʻana o nā mea lawe lāʻau lapaʻau, a me ka hanaʻana i nā mea hana paʻa.
Ke komo nei nā lāʻau lapaʻau pilikino i ka hoʻohiki nui no ka hoʻomaikaʻiʻana i ka maikaʻi o ʻO ka laweʻana i ka laweʻana i ka lāʻau lapaʻau no ka maʻi maʻi. ^. Ma ka tailoring i ka hoʻolālāʻana i nā hiʻohiʻona pilikino o kēlā me kēia mea maʻi a me kā lākou mea e ulu ai, hiki paha ke hoʻonui i ka laweʻana i ka lāʻau lapaʻau E pili paha kēia i ka nānāʻana i kaʻike genetic o ka tumor e hoʻomaopopo i nā pahuhopu kiko'ī no ka laweʻana i ka lāʻau lapaʻau.
ʻO ka inoa lāʻau | Kaukai | ʻAno maʻi kanesa | Mechanism o ka hana |
---|---|---|---|
Draxil? | Tumor vasculature | Ovarian canicer, lehulehu myeloma, ka sarcomoma | Ka lōʻihi o ka pōkole, hoʻonui i ka hōʻiliʻili i nā tumors |
Kadcyla? | Herp2 | Her2-maikaʻi metastic umauma maʻi maʻi maʻi | Ua hoʻopiliʻiaʻo Her2-Spellbody antibody i kahi inthibule micrubule |
ENTERU? | Herp2 | Her2-maikaʻi umauma maʻi maʻi | Ua hoʻopiliʻiaʻo Her2-Spellbody antibody i kahi topoisomese i ka inoibitor |
Hōʻike: ʻO kēiaʻatikala no kaʻikeʻike aʻikeʻoleʻia e noʻonoʻoʻia e like me ke aʻoʻana o ka lāʻau lapaʻau. Kūkākūkā me kahiʻoihana olakino kūpono no ka maʻi maʻi a me ka mālamaʻana i ka maʻi maʻi.